Bpc 157 - NutraPedia

Back to Table of Contents

BPC 157 Overview

1) Conditions Studied

BPC 157 has been studied for a variety of conditions, including:

  • Gastrointestinal tract disorders
  • Soft tissue injuries
  • Inflammation-related diseases
  • Wound healing and tissue repair
  • Bone and joint healing
  • Neuroprotective effects

2) Efficacy in Treating Conditions

Research, mostly in animal models, suggests that BPC 157 may be effective in treating the above conditions through its regenerative and healing properties. However, more human clinical trials are needed to determine its efficacy and safety in treating these conditions.

3) Health Benefits

BPC 157 is believed to offer several health benefits, such as:

  • Promoting wound healing and tissue repair
  • Reducing inflammation
  • Improving digestive function
  • Enhancing bone and joint recovery
  • Possessing potential neuroprotective properties

4) Downsides

While BPC 157 is regarded as safe based on animal studies, potential downsides include:

  • Limited data on long-term safety and side effects in humans
  • Possible regulatory issues as it is not approved by major health agencies like the FDA
  • Risk of contamination or inaccurate dosing when sourced from unverified suppliers

5) Genetic Variations and Effects

Currently, there is limited research on the interaction between BPC 157 and specific genetic variations. As such, it is not well-understood whether it is particularly beneficial or harmful for certain genetic profiles. Personalized medicine approaches could potentially uncover these relationships in the future.

Summary of BPC 157's Therapeutic Potential

Gastric Pentadecapeptide BPC 157 is a stable peptide with a variety of reported therapeutic effects across multiple biological systems. Its potential applications range from musculoskeletal healing to gastrointestinal recovery and central nervous system protection.

Musculoskeletal Healing

BPC 157 may offer benefits as a conservative treatment or recovery aid for soft tissue injuries such as in tendons and ligaments. It has shown positive results in animal studies for promoting healing, but confirmation in human effectiveness is pending.

Gastrointestinal Recovery

With anti-ulcer and wound healing properties, BPC 157 has demonstrated effectiveness in treating inflammatory bowel disease (IBD) and related severe complications without noted side effects. Its ability to protect endothelial cells and stimulate angiogenesis and collagen formation makes it a promising agent for gastrointestinal therapies.

Central Nervous System Protection

BPC 157 exhibits potential for treating central nervous system disorders, such as stroke, schizophrenia, and spinal cord injury, through modulation of gene expression and various biological systems.

Counteracting NSAID Side Effects

BPC 157 may serve as an antidote to side effects caused by nonsteroidal anti-inflammatory drugs (NSAIDs), including gastrointestinal lesions and bleeding disorders, due to its safety profile and consistent effective dosing.

COVID-19 Treatment Potential

The peptide's impact on vascular integrity and immune response suggests that BPC 157 could be beneficial for managing COVID-19 complications; however, further clinical development is required.

Tendon Healing

Research indicates that BPC 157 enhances tendon repair by promoting cell growth, survival, and movement, likely through the FAK-paxillin signaling pathway.

Myotendinous Junction Recovery

BPC 157 effectively restores the myotendinous junction, aiding in the healing of transected muscle, tendon, and ligament injuries, as evidenced by improved functional recovery in animal models.

Wound Healing

The peptide's broad healing capabilities extend to various wound types, and it shows potential in treating bleeding disorders and enabling vessel circumvention, which could be beneficial in ischemia/reperfusion scenarios.

Organoprotection

BPC 157, identified as a protective agent within gastric juice, may mediate organ protection against various stressors without affecting baseline physiological parameters or exhibiting toxicity, suggesting a new class of therapeutic agents.

Despite the promising data from animal studies, further research and clinical trials are needed to confirm the safety and efficacy of BPC 157 in human medicine.

References:


  1. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
  2. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157
  3. Pentadecapeptide BPC 157 and the central nervous system
  4. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
  5. BPC 157 as Potential Treatment for COVID-19
  6. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
  7. Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats
  8. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
  9. A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC
  10. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application
  11. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application
  12. The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice
  13. The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam
  14. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
  15. Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle
  16. Stable gastric pentadecapeptide BPC 157 and bupivacaine
  17. BPC 157 and blood vessels
  18. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice
  19. Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats
  20. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of N(G)-nitro-L-arginine methyl ester and L-arginine
  21. Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats
  22. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
  23. Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator
  24. Antiinflammatory effect of BPC 157 on experimental periodontitis in rats
  25. Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy
  26. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain
  27. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
  28. Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome
  29. Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats
  30. Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
  31. BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats
  32. The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
  33. Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro
  34. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing
  35. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances
  36. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats
  37. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat
  38. The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants
  39. BPC 157's effect on healing
  40. Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation
  41. Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice
  42. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection
  43. Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
  44. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation
  45. Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy
  46. High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736)
  47. Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing
  48. Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice
  49. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing
  50. Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future
  51. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro
  52. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
  53. The pharmacological properties of the novel peptide BPC 157 (PL-10)
  54. Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats


Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!